Ongoing trials in Alzheimer’s disease

ISSN： 1354-3784

Source： Expert Opinion on Investigational Drugs, Vol.9, Iss.4, 2000-04, pp. : 899-915

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Immunotherapy for Alzheimer's Disease: Rational Basis in Ongoing Clinical Trials

Current Pharmaceutical Design, Vol. 17, Iss. 5, 2011-02 ,pp. : 508-520

Bentham Science Publishers

Access to resources Recommend Favorite

Recruitment and Retention Strategies for Clinical Trials in Alzheimers Disease

By Sabbagh M.N.

Pharmaceutical Development and Regulation, Vol. 1, Iss. 4, 2003-01 ,pp. : 269-276

Adis International

Access to resources Recommend Favorite

Alzheimer’s Disease

Cells Tissues Organs, Vol. 162, Iss. 1, 1998-10 ,pp. : 46-55

Karger

Access to resources Recommend Favorite

Antioxidant Clinical Trials in Mild Cognitive Impairment and Alzheimer’s disease – Challenges and Perspectives

Current Pharmaceutical Design, Vol. 20, Iss. 18, 2014-06 ,pp. : 3083-3092

Bentham Science Publishers

Access to resources Recommend Favorite

Conference Report: 10th Clinical Trials on Alzheimer's Disease (CTAD), Boston MA, USA, November 1-4, 2017

CNS & Neurological Disorders - Drug Targets (Formerly Current Drug Targets - CNS & Neurological Disorders), Vol. 16, Iss. 10, 2018-03 ,pp. : 1134-1137

Bentham Science Publishers

Access to resources Recommend Favorite